Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/apt.16349 http://scihub22266oqcxt.onion/10.1111/apt.16349 33961708!8207069!33961708     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33961708&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Aliment+Pharmacol+Ther 2021 ; 53 (11): 1236-1240 Nephropedia Template TP {{tp|p=33961708|t=2021. Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study |pdf=|usr=}}{{33961708}} gab.com Text Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study JO: Aliment Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=33961708 #FOAvip LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804 Twit Text FOAVip Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study ????Aliment Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=33961708 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33961708 #FOAvip English Wikipedia <ref>{{Cite pmid|33961708}}</ref> Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study #MMPMID33961708 Lamb CA; Sebastian S; Kent AJ; Segal JP; Gonzalez HA; Brookes MJ; Mehta SJ; Subramanian S; Bhala N; Hicks LC; Conley TE; Patel KV; Walker GJ; Kennedy NA Aliment Pharmacol Ther 2021[Jun]; 53 (11): 1236-1240 PMID33961708show ga LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804 |*COVID-19[MESH] |*Inflammatory Bowel Diseases/complications/drug therapy/epidemiology[MESH] |Cohort Studies[MESH] |Humans[MESH] |SARS-CoV-2[MESH]Letter: risk of severe COVID-19 outcomes associated with inflammatory (epmc).pdf DeepDyve Pubget Overpricing